These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 418802)

  • 1. Preparation of a semisynthetic antibody.
    Gavish M; Zakut R; Wilchek M; Givol D
    Biochemistry; 1978 Apr; 17(7):1345-51. PubMed ID: 418802
    [No Abstract]   [Full Text] [Related]  

  • 2. Origins of antibody complementarity and specificity--hypervariable regions and minigene hypothesis.
    Kabat EA
    J Immunol; 1980 Sep; 125(3):961-9. PubMed ID: 6774021
    [No Abstract]   [Full Text] [Related]  

  • 3. The structural basis of antigenic determinants on V kappa 21 light chains.
    Julius MA; McKean DJ; Potter M; Feldmann RJ; Weigert M
    Mol Immunol; 1981 Jan; 18(1):1-9. PubMed ID: 6167848
    [No Abstract]   [Full Text] [Related]  

  • 4. Preparation and characterization of anti-framework antibodies to the kappa-chain variable region (V kappa) of mouse immunoglobulins.
    Ben-Neriah Y; Lonai P; Givol D
    J Immunol; 1980 Feb; 124(2):691-5. PubMed ID: 6766163
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of an idiotype (Id-460) during in vivo anti-dinitrophenyl antibody responses. I. Mapping of genes for Id-460 expression to the variable region of immunoglobulin heavy-chain locus and to the variable region of immunoglobulin kappa-light-chain locus.
    Dzierzak EA; Janeway CA; Rosenstein RW; Gottlieb PD
    J Exp Med; 1980 Sep; 152(3):720-9. PubMed ID: 6774049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the diversity of murine antibodies to dextran B1355: N-terminal amino acid sequences of heavy chains from serum antibody.
    Schilling J; Hansburg D; Davie JM; Hood L
    J Immunol; 1979 Jul; 123(1):384-8. PubMed ID: 109537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the role of Tyr 34L in the antibody combining site of the dinitrophenyl binding protein 315.
    Gavish M; Neriah YB; Zakut R; Givol D; Dwek RA; Jackson WR
    Mol Immunol; 1979 Nov; 16(11):957-63. PubMed ID: 43280
    [No Abstract]   [Full Text] [Related]  

  • 8. Phosphorylcholine-binding hybridoma proteins of normal and idiotypically suppressed BALB/c mice II. Variable region N-terminal amino acid sequences.
    Kocher HP; Berek C; Schreier MH; Cosenza H; Jaton JC
    Eur J Immunol; 1980 Apr; 10(4):264-7. PubMed ID: 6772452
    [No Abstract]   [Full Text] [Related]  

  • 9. Serological distinciton of heavy chain variable regions (VH subgroups) of mouse immunoglobulins. I. Common VH determinants on the heavy chains of mouse myeloma proteins having different binding sites.
    Bosma MJ; De Witt C; Hausman SJ
    J Exp Med; 1977 Oct; 146(4):104l-53. PubMed ID: 70500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The location and expression of idiotypic determinants in the immunoglobulin variable region--II. Chain location of variable region determinants.
    Zeldis JB; Konigsberg WH; Richards FF; Rosenstein RW
    Mol Immunol; 1979 Jun; 16(6):371-8. PubMed ID: 90645
    [No Abstract]   [Full Text] [Related]  

  • 11. Structural studies on induced antibodies with defined idiotypic specificities. IX. Framework differences in the heavy- and light-chain-variable regions of monoclonal anti-p-azophenylarsonate antibodies from A/J mice differing with respect to a cross-reactive idiotype.
    Estess P; Lamoyi E; Nisonoff A; Capra JD
    J Exp Med; 1980 Apr; 151(4):863-75. PubMed ID: 6768828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model-building studies of antigen-binding sites: the hapten-binding site of mopc-315.
    Padlan EA; Davies DR; Pecht I; Givol D; Wright C
    Cold Spring Harb Symp Quant Biol; 1977; 41 Pt 2():627-37. PubMed ID: 268248
    [No Abstract]   [Full Text] [Related]  

  • 13. Unusual distributions of amino acids in complementarity-determining (hypervariable) segments of heavy and light chains of immunoglobulins and their possible roles in specificity of antibody-combining sites.
    Kabat EA; Wu TT; Bilofsky H
    J Biol Chem; 1977 Oct; 252(19):6609-16. PubMed ID: 408353
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure of antibody combining sites.
    Kabat EA
    Ann Immunol (Paris); 1976; 127(3-4):239-52. PubMed ID: 822774
    [No Abstract]   [Full Text] [Related]  

  • 15. Origins of antibody diversity: insight gained from amino acid sequence studies of elicited antibodies.
    Haber E; Margolies MN; Cannon LE
    Cold Spring Harb Symp Quant Biol; 1977; 41 Pt 2():647-59. PubMed ID: 19193
    [No Abstract]   [Full Text] [Related]  

  • 16. Serological detection of variable region (Vh) subgroups of Ig heavy chains.
    Forre O; Natvig JB; Kunkel HG
    J Exp Med; 1976 Oct; 144(4):897-905. PubMed ID: 62015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of antibodies to the lambda chain variable region (Vlambda) of mouse immunoglobulins.
    Ben-Neriah Y; Lonai P; Gavish M; Givol D
    Eur J Immunol; 1978 Nov; 8(11):792-6. PubMed ID: 82511
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthetic peptides VH(27-68) and VH(16-68) of the myeloma immunoglobulin M603 heavy chain and their association with the natural light chain to form an antigen binding site.
    Kubiak T; Whitney DB; Merrifield RB
    Biochemistry; 1987 Dec; 26(24):7849-55. PubMed ID: 3122833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody diversity versus antibody complementarity.
    Kabat EA
    Pharmacol Rev; 1982 Mar; 34(1):23-38. PubMed ID: 6803258
    [No Abstract]   [Full Text] [Related]  

  • 20. Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments.
    Clarke SH; Kenny JJ; Sieckmann DG; Rudikoff S
    J Immunol; 1984 Mar; 132(3):1544-9. PubMed ID: 6420465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.